The study of Golgi apparatus in Alzheimer's disease

Neurochemical Research

Volumn 32, Issue 8, 2007, Pages 1265-1277

  Hu, Zhiping ^a   Zeng, Liuwang ^a   Huang, Zhiling ^a   Zhang, Jie ^a   Li, Ting ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Alzheimer's disease; Amyloid protein; Amyloid precursor protein; Gamma secretase; Golgi apparatus; Presenilins; Tau

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-42]; AMYLOID PRECURSOR PROTEIN; ANTERIOR PHARYNX DEFECTIVE 1 PROTEIN; BETA SECRETASE; CALCIUM ION; ESTROGEN; FLAVINE ADENINE NUCLEOTIDE; GAMMA SECRETASE; GLYCOSPHINGOLIPID; MINTS PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE KINASE; NICASTRIN; PHOSPHOLIPASE D1; PRESENILIN 1; PRESENILIN 2; PROTEIN; PROTEIN SYX5; RECEPTOR; SORTING PROTEIN RELATED RECEPTOR; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; APOPTOSIS; CELL SURFACE; COGNITION; ENDOPLASMIC RETICULUM; ENZYME ACTIVITY; ESTROGEN THERAPY; GOLGI COMPLEX; HUMAN; INTRACELLULAR SPACE; NEUROPATHOLOGY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN METABOLISM; PROTEIN TARGETING; REVIEW; SENILE PLAQUE;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; AMYLOID PRECURSOR PROTEIN SECRETASES; ANIMALS; APOPTOSIS; CALCIUM; GOLGI APPARATUS; HORMONES; HUMANS; MEMBRANE GLYCOPROTEINS; MEMBRANE PROTEINS; PRESENILINS; TAU PROTEINS;

EID: 34250890136     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11064-007-9302-4     Document Type: Review

References (92)

1. Cruz JC, Tsai LH (2004) Cdk5 deregulation in the pathogenesis of Alzheimer's disease. Trends Mol Med 10(9):452-8
2. Yesavage JA, O'Hara R, Kraemer H et al (2002) Modeling the prevalence and incidence of Alzheimer's disease and mild cognitive impairment. J Psychiatr Res 36(5):281-6
3. Machamer CE (2003) Golgi disassembly in apoptosis: cause or effect? Trends Cell Biol 13(6):279-81
4. Rios RM, Bornens M (2003) The Golgi apparatus at the cell centre. Curr Opin Cell Biol. 15:60-66
5. Gonatas NK (1997) The Golgi apparatus in disease. In: Berger EG, Roth J (eds) The Golgi apparatus. Birkhauser Verlag, Basel, pp. 247-273
6. Swaab DF, Dubelaar EJ, Scherder EJ et al (2003) Therapeutic strategies for Alzheimer disease: focus on neuronal reactivation of metabolically impaired neurons. Alzheimer Dis Assoc Disord 17(Suppl 4):S114-22
7. Ishunina TA, Swaab DF (2003) Increased neuronal metabolic activity and estrogen receptors in the vertical limb of the diagonal band of Broca in Alzheimer's disease: relation to sex and aging. Exp Neurol 183(1):159-72
8. Hock C, Heese K, Hulette C et al (2000) Region-specific neurotrophin imbalances in Alzheimer disease: decreased levels of brain-derived neurotrophic factor and increased levels of nerve growth factor in hippocampus and cortical areas. Arch Neurol 57(6):846-51
9. Dubelaar EJ, Mufson EJ, ter Meulen WG et al (2006) Increased metabolic activity in nucleus basalis of Meynert neurons in elderly individuals with mild cognitive impairment as indicated by the size of the Golgi apparatus. J Neuropathol Exp Neurol 65(3):257-66
10. Dubelaar EJ, Verwer RW, Hofman MA et al (2004) ApoE epsilon4 genotype is accompanied by lower metabolic activity in nucleus basalis of Meynert neurons in Alzheimer patients and controls as indicated by the size of the Golgi apparatus. J Neuropathol Exp Neurol 63(2):159-69
11. Ishunina TA, Kamphorst W, Swaab DF (2003) Changes in metabolic activity and estrogen receptors in the human medial mamillary nucleus: relation to sex, aging and Alzheimer's disease. Neurobiol Aging 24(6):817-28
12. Tamboli IY, Prager K, Barth E (2005) Inhibition of glycosphingolipid biosynthesis reduces secretion of the beta-amyloid precursor protein and amyloid beta-peptide. J Biol Chem 280(30):28110-7
13. Biederer T, Cao X, Sudhof TC et al (2002) Regulation of APP-dependent transcription complexes by Mint/X11s: differential functions of Mint isoforms. J Neurosci 22(17):7340-51
14. Andersen OM, Reiche J, Schmidt V (2005) Neuronal sorting protein-related receptor sorLA/LR11 regulates processing of the amyloid precursor protein. Proc Natl Acad Sci USA 102(38):13461-6
15. Andersen OM, Schmidt V, Spoelgen R et al (2006) Molecular dissection of the interaction between amyloid precursor protein and its neuronal trafficking receptor SorLA/LR11. Biochemistry 45(8):2618-28
16. Spoelgen R, von Arnim CA, Thomas AV et al (2006) Interaction of the cytosolic domains of sorLA/LR11 with the amyloid precursor protein (APP) and beta-secretase beta-site APP-cleaving enzyme. J Neurosci 26(2):418-28
17. Suga K, Saito A, Tomiyama T et al (2005) syntaxin5 interacts specifically with presenilin holoproteins and affects processing of betaAPP in neuronal cells. J Neurochem 94(2):425-39
18. Suga K, Tomiyama T, Mori H et al (2004) syntaxin5 interacts with presenilin holoproteins, but not with their N- or C-terminal fragments, and affects beta-amyloid peptide production. Biochem J 381(Pt 3):619-28
19. Takahashi RH, Nam EE, Edgar M et al (2002) Alzheimer beta-amyloid peptides: normal and abnormal localization. Histol Histopathol 17(1):239-46
20. Annaert WG, Levesque L, Craessaerts K et al (1999) Presenilin 1 controls gamma-secretase processing of amyloid precursor protein in pre-golgi compartments of hippocampal neurons. J Cell Biol 147(2):277-94
21. Rechards M, Xia W, Oorschot VM et al (2003) Presenilin-1 exists in both pre- and post-Golgi compartments and recycles via COPI-coated membranes. Traffic 4(8):553-65
22. Greenfield JP, Tsai J, Gouras GK et al (1999) Endoplasmic reticulum and trans-Golgi network generate distinct populations of Alzheimer beta-amyloid peptides. Proc Natl Acad Sci USA 96(2):742-7
23. Hama E, Shirotani K, Iwata N et al (2004) Effects of neprilysin chimeric proteins targeted to subcellular compartments on amyloid beta peptide clearance in primary neurons. J Biol Chem 279(29):30259-64
24. Sun X, Cole GM, Chu T et al (2002) Intracellular Abeta is increased by okadaic acid exposure in transfected neuronal and non-neuronal cell lines. Neurobiol Aging 23(2):195-203
25. Takeda K, Araki W, Tabira T (2004) Enhanced generation of intracellular Abeta42 amyloid peptide by mutation of presenilins PS1 and PS2. Eur J Neurosci 19(2):258-264
26. Lopez EM, Bell KF, Ribeiro-da-Silva A et al (2004) Early changes in neurons of the hippocampus and neocortex in transgenic rats expressing intracellular human a-beta. J Alzheimers Dis 6(4):421-31
27. Tabira T, Chui DH, Kuroda S (2002) Significance of intracellular Abeta42 accumulation in Alzheimer's disease. Front Biosci 7:a44-9
28. Echeverria V, Cuello AC (2002) Intracellular A-beta amyloid, a sign for worse things to come?. Mol Neurobiol 26(2-3):299-316
29. Shiba T, Kametaka S, Kawasaki M et al (2004) Insights into the phosphoregulation of beta-secretase sorting signal by the VHS domain of GGA1. Traffic 5(6):437-48
30. Vassar R, Bennett BD, Babu-Khan S et al (1999) Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science 286(5440):735-41
31. Yan R, Han P, Miao H et al (2001) The transmembrane domain of the Alzheimer's beta-secretase (BACE1) determines its late Golgi localization and access to beta -amyloid precursor protein (APP) substrate. J Biol Chem 276(39):36788-96
32. Huse JT, Liu K, Pijak DS et al (2002) Beta-secretase processing in the trans-Golgi network preferentially generates truncated amyloid species that accumulate in Alzheimer's disease brain. J Biol Chem 277(18):16278-84
33. Fluhrer R, Capell A, Westmeyer G et al (2002) A non-amyloidogenic function of BACE-2 in the secretory pathway. J Neurochem 81(5):1011-20
34. Baulac S, LaVoie MJ, Kimberly WT et al (2003) Functional gamma-secretase complex assembly in Golgi/trans-Golgi network: interactions among presenilin, nicastrin, Aph1, Pen-2, and gamma-secretase substrates. Neurobiol Dis 14(2):194-204
35. Wrigley JD, Schurov I, Nunn EJ et al (2005) Functional overexpression of gamma-secretase reveals protease-independent trafficking functions and a critical role of lipids for protease activity. J Biol Chem 280(13):12523-35
36. Tomita T, Watabiki T, Takikawa R et al (2001) The first proline of PALP motif at the C terminus of presenilins is obligatory for stabilization, complex formation, and gamma-secretase activities of presenilins. J Biol Chem 276(35):33273-81
37. Siman R, Velji J (2003) Localization of presenilin-nicastrin complexes and gamma-secretase activity to the trans-Golgi network. J Neurochem 84(5):1143-53
38. Cupers P, Bentahir M, Craessaerts K et al (2001) The discrepancy between presenilin subcellular localization and gamma-secretase processing of amyloid precursor protein. J Cell Biol 154(4):731-40
39. Kaether C, Lammich S, Edbauer D et al (2002 Presenilin-1 affects trafficking and processing of betaAPP and is targeted in a complex with nicastrin to the plasma membrane. J Cell Biol 158(3):551-61
40. Kasa P, Papp H, Pakaski M (2001) Presenilin-1 and its N-terminal and C-terminal fragments are transported in the sciatic nerve of rat. Brain Res 909(1-2):159-69
41. Xia W, Ray WJ, Ostaszewski BL et al (2000) Presenilin complexes with the C-terminal fragments of amyloid precursor protein at the sites of amyloid beta-protein generation. Proc Natl Acad Sci USA 97(16):9299-304
42. Rechards M, Xia W, Oorschot V et al (2006) Presenilin-1-mediated retention of APP derivatives in early biosynthetic compartments. Traffic 7(3):354-64
43. Yang DS, Tandon A, Chen F et al (2002) Mature glycosylation and trafficking of nicastrin modulate its binding to presenilins. J Biol Chem 277(31):28135-42
44. Leem JY, Vijayan S, Han P et al (2002) Presenilin 1 is required for maturation and cell surface accumulation of nicastrin. J Biol Chem 277(21):19236-40
45. Herreman A, Van Gassen G, Bentahir M et al (2003) gamma-Secretase activity requires the presenilin-dependent trafficking of nicastrin through the Golgi apparatus but not its complex glycosylation. J Cell Sci 116(Pt 6):1127-36
46. Yu G, Nishimura M, Arawaka S et al (2000) Nicastrin modulates presenilin-mediated notch/glp-1 signal transduction and betaAPP processing. Nature 407(6800):48-54
47. Gu Y, Chen F, Sanjo N et al (2003) APH-1 interacts with mature and immature forms of presenilins and nicastrin and may play a role in maturation of presenilin.nicastrin complexes. J Biol Chem 278(9):7374-80
48. Niimura M, Isoo N, Takasugi N et al (2005) Aph-1 contributes to the stabilization and trafficking of the gamma-secretase complex through mechanisms involving intermolecular and intramolecular interactions. J Biol Chem 280(13):12967-75
49. Wang H, Luo WJ, Zhang YW et al (2004) Presenilins and gamma-secretase inhibitors affect intracellular trafficking and cell surface localization of the gamma-secretase complex components. J Biol Chem 279(39):40560-6
50. Kawamata T, Taniguchi T, Mukai H et al (1998) A protein kinase, PKN, accumulates in Alzheimer neurofibrillary tangles and associated endoplasmic reticulum-derived vesicles and phosphorylates tau protein. J Neurosci 18(18):7402-10
51. Elyaman W, Yardin C, Hugon J (2002) Involvement of glycogen synthase kinase-3beta and tau phosphorylation in neuronal Golgi disassembly. J Neurochem 81(4):870-80
52. Grieb P, Gordon-Krajcer W, Frontczak-Baniewicz M et al (2004) 2-deoxyglucose induces beta-APP overexpression, tau hyperphosphorylation and expansion of the trans-part of the Golgi complex in rat cerebral cortex. Acta Neurobiol Exp (Wars) 64(4):491-502
53. Liazoghli D, Perreault S, Micheva KD et al (2005) Fragmentation of the Golgi apparatus induced by the overexpression of wild-type and mutant human tau forms in neurons. Am J Pathol 166(5):1499-514
54. Tanemura K, Murayama M, Akagi T et al (2002) Neurodegeneration with tau accumulation in a transgenic mouse expressing V337M human tau. J Neurosci 22(1):133-41
55. Stamer K, Vogel R, Thies E et al (2002) Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress. J Cell Biol 156(6):1051-63
56. Zhao Z, Ksiezak-Reding H, Wang J et al (2005) Expression of tau reduces secretion of Abeta without altering the amyloid precursor protein content in CHOsw cells. FEBS Lett 579(10):2119-24
57. Campbell WA, Iskandar MK, Reed ML et al (2002) Endoproteolysis of presenilin in vitro: inhibition by gamma-secretase inhibitors. Biochemistry 41(10):3372-9
58. Petanceska SS, Seeger M, Checler F et al (2000) Mutant presenilin 1 increases the levels of Alzheimer amyloid beta-peptide Abeta42 in late compartments of the constitutive secretory pathway. J Neurochem 74(5):1878-84
59. Sudoh S, Hua G, Kawamura Y et al (2000) Intracellular site of gamma-secretase cleavage for Abeta42 generation in neuro 2a cells harbouring a presenilin 1 mutation. Eur J Biochem 267(7):2036-45
60. Cai D, Leem JY, Greenfield JP et al (2003) Presenilin-1 regulates intracellular trafficking and cell surface delivery of beta-amyloid precursor protein. J Biol Chem 278(5):3446-54
61. Kametani F, Usami M, Tanaka K et al (2004) Mutant presenilin (A260V) affects Rab8 in PC12D cell. Neurochem Int 44(5):313-20
62. Farquhar MJ, Gray CW, Breen KC et al (2003) The over-expression of the wild type or mutant forms of the presenilin-1 protein alters glycoprotein processing in a human neuroblastoma cell line. Neurosci Lett 346(1-2):53-6
63. Figueroa DJ, Morris JA, Ma L et al (2002) Presenilin-dependent gamma-secretase activity modulates neurite outgrowth. Neurobiol Dis 9(1):49-60
64. Cai D, Zhong M, Wang R et al (2006) Phospholipase D1 corrects impaired betaAPP trafficking and neurite outgrowth in familial Alzheimer's disease-linked presenilin-1 mutant neurons. Proc Natl Acad Sci USA 103(6):1936-40
65. Cai D, Netzer WJ, Zhong M et al (2006) Presenilin-1 uses phospholipase D1 as a negative regulator of beta-amyloid formation. Proc Natl Acad Sci USA 103(6):1941-6
66. Culvenor JG, Evin G, Cooney MA et al (2000) Presenilin 2 expression in neuronal cells: induction during differentiation of embryonic carcinoma cells. Exp Cell Res 255(2):192-206
67. Tekirian TL, Merriam DE, Marshansky V et al (2001) Subcellular localization of presenilin 2 endoproteolytic C-terminal fragments. Brain Res Mol Brain Res 96(1-2):14-20
68. Iwata H, Tomita T, Maruyama K et al (2001) Subcellular compartment and molecular subdomain of beta-amyloid precursor protein relevant to the Abeta 42-promoting effects of Alzheimer mutant presenilin 2. J Biol Chem 276(24):21678-85
69. Ishunina TA, van Heerikhuize JJ, Ravid R et al (2003) Estrogen receptors and metabolic activity in the human tuberomamillary nucleus: changes in relation to sex, aging and Alzheimer's disease. Brain Res 988(1-2):84-96
70. Ishunina TA, Wouda J, Fisser B et al (2002) Sex differences in estrogen receptor alpha and beta expression in vasopressin neurons of the supraoptic nucleus in elderly and Alzheimer's disease patients: no relationship with cytoskeletal alterations. Brain Res 951(2):322-9
71. Greenfield JP, Leung LW, Cai D et al (2002) Estrogen lowers Alzheimer beta-amyloid generation by stimulating trans-Golgi network vesicle biogenesis. J Biol Chem 277(14):12128-36
72. Gasparini L, Gouras GK, Wang R et al (2001) Stimulation of beta-amyloid precursor protein trafficking by insulin reduces intraneuronal beta-amyloid and requires mitogen-activated protein kinase signaling. J Neurosci 21(8):2561-70
73. Schechter R, Beju D, Miller KE et al (2005) The effect of insulin deficiency on tau and neurofilament in the insulin knockout mouse. Biochem Biophys Res Commun 334(4):979-86
74. Grieb P, Kryczka T, Fiedorowicz M et al (2004) Expansion of the Golgi apparatus in rat cerebral cortex following intracerebroventricular injections of streptozotocin. Acta Neurobiol Exp (Wars) 64(4):481-9
75. LaFerla FM (2002) Calcium dyshomeostasis and intracellular signalling in Alzheimer's disease. Nat Rev Neurosci 3(11):862-72
76. Pinton P, Pozzan T, Rizzuto R et al (1998) The Golgi apparatus is an inositol 1,4,5-trisphosphate-sensitive Ca2 + store, with functional properties distinct from those of the endoplasmic reticulum. EMBO J 17(18):5298-308
77. Leissring MA, Parker I, LaFerla FM (1999) Presenilin-2 mutations modulate amplitude and kinetics of inositol 1, 4,5-trisphosphate-mediated calcium signals. J Biol Chem 274(46):32535-8
78. Leissring MA, Paul BA, Parker I et al (1999) Alzheimer's presenilin-1 mutation potentiates inositol 1,4,5-trisphosphate-mediated calcium signaling in Xenopus oocytes. J Neurochem 72(3):1061-8
79. Zatti G, Burgo A, Giacomello M et al (2006) Presenilin mutations linked to familial Alzheimer's disease reduce endoplasmic reticulum and Golgi apparatus calcium levels. Cell Calcium 39(6):539-50
80. Gonatas NK, Stieber A, Gonatas JO (2006) Fragmentation of the Golgi apparatus in neurodegenerative diseases and cell death. J Neurol Sci 246(1-2):21-30
81. Terro F, Czech C, Esclaire F et al (2002) Neurons overexpressing mutant presenilin-1 are more sensitive to apoptosis induced by endoplasmic reticulum-Golgi stress. J Neurosci Res 69(4):530-9
82. Zhang Z, Hartmann H, Do VM et al (1998) Destabilization of beta-catenin by mutations in presenilin-1 potentiates neuronal apoptosis. Nature 395(6703):698-702
83. Lilliehook C, Chan S, Choi EK et al (2002) Calsenilin enhances apoptosis by altering endoplasmic reticulum calcium signaling. Mol Cell Neurosci 19(4):552-9
84. Coughlan CM, Breen KC (2000) Factors influencing the processing and function of the amyloid beta precursor protein-a potential therapeutic target in Alzheimer's disease?. Pharmacol Ther 86(2):111-45
85. Roberds SL, Anderson J, Basi G et al (2001) BACE knockout mice are healthy despite lacking the primary beta-secretase activity in brain: implications for Alzheimer's disease therapeutics. Hum Mol Genet 10(12):1317-24
86. Sun X, Tong Y, Qing H et al (2006) Increased BACE1 maturation contributes to the pathogenesis of Alzheimer's disease in Down syndrome. FASEB J 20(9):1361-8
87. Sun X, He G, Song W (2006) BACE2, as a novel APP theta-secretase, is not responsible for the pathogenesis of Alzheimer's disease in Down syndrome. FASEB J 20(9):1369-76
88. von Arnim CA, Spoelgen R, Peltan ID et al (2006) GA1 acts as a spatial switch altering amyloid precursor protein trafficking and processing. J Neurosci 26(39):9913-22
89. Gandy S, Doeven MK, Poolman B (2006) Alzheimer disease: presenilin springs a leak. Nat Med 12(10):1121-3
90. Salehi A, Swaab DF (1999) Diminished neuronal metabolic activity in Alzheimer's disease. J Neural Transm 106(9-10):955-86
91. Ishunina TA, Fischer DF, Swaab DF (2006) Estrogen receptor alpha and its splice variants in the hippocampus in aging and Alzheimer's disease. Neurobiol Aging. 26
92. Hoyer S (2004) Causes and consequences of disturbances of cerebral glucose metabolism in sporadic Alzheimer disease: therapeutic implications. Adv Exp Med Biol 541:135-52